Loading...
New treatments for asthma: the role of leukotriene modifier agents.
The three leukotriene (LT) modifiers approved for use in the United States, zileuton, zafirlukast, and montelukast, are the first new class of therapeutic agents to be introduced in 20 years for the treatment of asthma. These agents are referred to as leukotriene modifiers and have clearly demonstra...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
National Medical Association
1999
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2608482/ https://ncbi.nlm.nih.gov/pubmed/12653390 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|